跳至主要内容
临床试验/NCT00755989
NCT00755989撤回不适用

A Phase 3, Single-centered, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Trial of Morphine Sulfate Gel 0.1% in Patients With Stage 2-3 Wounds

Banner Health2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Banner Health
入组人数
100
试验地点
2
主要终点
Safety and efficacy with the use of morphine gel applied topically for pain control

研究概览

简要总结

Morphine gel applied topically to wounds will reduce wound pain and decrease patients use of oral and intravenous pain medications, therefore reducing side effects.

详细描述

Patients will be randomized to receive either placebo (versa base gel) or morphine gel to wound. Patients receiving morphine gel will have a decrease in pain score and use less oral/intravenous pain medications.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
Double (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed and dated consent form & HIPAA
  • >/= 18 yo
  • Single stage 2-3 wound evaluated by our wound care team
  • Alert and oriented (thinking ability clear and intact, physician approval)
  • English language proficiency, likely to be able to participate in all scheduled evaluations

排除标准

  • Allergy to morphine, codeine, or versa base
  • pts taking medications for acute condition, other than for the wound pain (can be taking chronic pain meds if current dose stable for past 3 mo)
  • Patients with neuropathies
  • Patients with respiratory conditions
  • Patients that are pregnant

结局指标

主要结局

Safety and efficacy with the use of morphine gel applied topically for pain control

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
Banner Health
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验